Alhambra Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $729K | Buy |
3,929
+432
| +12% | +$80.2K | 0.36% | 67 |
|
|
2025
Q1 | $733K | Buy |
3,497
+2
| +0.1% | +$419 | 0.38% | 62 |
|
|
2024
Q4 | $621K | Buy |
3,495
+360
| +11% | +$64K | 0.32% | 75 |
|
|
2024
Q3 | $619K | Buy |
3,135
+4
| +0.1% | +$790 | 0.32% | 78 |
|
|
2024
Q2 | $537K | Buy |
3,131
+555
| +22% | +$95.2K | 0.29% | 82 |
|
|
2024
Q1 | $469K | Sell |
2,576
-113
| -4% | -$20.6K | 0.26% | 103 |
|
|
2023
Q4 | $417K | Sell |
2,689
-74
| -3% | -$11.5K | 0.25% | 105 |
|
|
2023
Q3 | $412K | Sell |
2,763
-69
| -2% | -$10.3K | 0.27% | 100 |
|
|
2023
Q2 | $382K | Sell |
2,832
-39
| -1% | -$5.26K | 0.25% | 104 |
|
|
2023
Q1 | $458K | Buy |
2,871
+125
| +5% | +$19.9K | 0.31% | 88 |
|
|
2022
Q4 | $444K | Sell |
2,746
-11
| -0.4% | -$1.78K | 0.32% | 89 |
|
|
2022
Q3 | $370K | Buy |
2,757
+1
| +0% | +$134 | 0.28% | 98 |
|
|
2022
Q2 | $422K | Sell |
2,756
-24
| -0.9% | -$3.68K | 0.31% | 92 |
|
|
2022
Q1 | $451K | Sell |
2,780
-835
| -23% | -$135K | 0.3% | 97 |
|
|
2021
Q4 | $490K | Sell |
3,615
-466
| -11% | -$63.2K | 0.34% | 89 |
|
|
2021
Q3 | $440K | Hold |
4,081
| – | – | 0.34% | 93 |
|
|
2021
Q2 | $460K | Buy |
4,081
+9
| +0.2% | +$1.01K | 0.35% | 91 |
|
|
2021
Q1 | $441K | Buy |
4,072
+238
| +6% | +$25.8K | 0.36% | 89 |
|
|
2020
Q4 | $411K | Sell |
3,834
-39
| -1% | -$4.18K | 0.44% | 80 |
|
|
2020
Q3 | $339K | Buy |
3,873
+984
| +34% | +$86.1K | 0.41% | 82 |
|
|
2020
Q2 | $284K | Buy |
+2,889
| New | +$284K | 0.37% | 77 |
|